TXA Seems Safe for Surgery in High-Risk Patients With IT Hip Fracture
THURSDAY, May 12, 2022 (HealthDay News) — For high-risk patients undergoing surgical repair for intertrochanteric hip fracture, tranexamic acid (TXA) is not associated with an increased risk for mortality or thromboembolic complications, according to…
Learn MorePrevious Myocardial Injury Tied to Worse COVID-19 Outcomes
THURSDAY, May 12, 2022 (HealthDay News) — Unvaccinated COVID-19 patients with preexisting myocardial injury have a substantially greater risk for six adverse COVID-19 outcomes, including death and severe disease, according to research published onlin…
Learn MoreCDC: Overdose Deaths Up 15 Percent in 2021
WEDNESDAY, May 11, 2022 (HealthDay News) — Provisional data from the National Center for Health Statistics at the U.S. Centers for Disease Control and Prevention show that U.S. overdose deaths in 2021 increased at half the pace of 2020 but are still…
Learn MoreFDA Moves to Ease Nationwide Shortage of Baby Formula
WEDNESDAY, May 11, 2022 (HealthDay News) – The U.S. Food & Drug Administration announced Tuesday that it is continuing its efforts to boost the country’s supply of infant formula.Amid shortages due to high demand and recall and supply issues, stores h…
Learn MoreEU Scraps Mask Mandate for Planes, Airports
WEDNESDAY, May 11, 2022 (HealthDay News) — The European Union mask mandate for airliners and airports will be dropped as of May 16, officials said Wednesday.The new guideline “takes account of the latest developments in the pandemic, in particular th…
Learn MoreLack of Asthma Control More Likely With COVID-19-Related Anxiety
WEDNESDAY, May 11, 2022 (HealthDay News) — Uncontrolled asthma is more likely among adults with asthma who have higher anxiety due to COVID-19, while most parents of children with food allergy (FA) reported unchanged or decreased FA-specific anxiety …
Learn MoreBan of Indoor Tanning Beds Would Reduce Cancers, Cut Costs
WEDNESDAY, May 11, 2022 (HealthDay News) — Introducing a ban on commercial indoor tanning with an accompanying public health campaign would reduce melanoma and keratinocyte cancers and reduce health care costs, according to a study recently published…
Learn MoreEspresso Consumption Linked to Increase in Serum Total Cholesterol
WEDNESDAY, May 11, 2022 (HealthDay News) — Consumption of espresso is associated with increased serum total cholesterol (S-TC), with a stronger association seen for men than women, according to a study published online May 10 in Open Heart.Åsne Lirhu…
Learn MoreHigh AI-ECG-AF Risk Score Tied to Worse Cognition, Cognitive Decline
WEDNESDAY, May 11, 2022 (HealthDay News) — An artificial intelligence-enabled electrocardiogram (AI-ECG) for atrial fibrillation (AF) is associated with cognition and may predict cognitive decline, according to a study published in the May issue of t…
Learn MoreSubcutaneous Implantable Defibrillators Cut Lead-Related Complications
WEDNESDAY, May 11, 2022 (HealthDay News) — Subcutaneous implantable defibrillators (S-ICDs) reduce the risk of lead-related complications by more than 90 percent, according to a study presented at the annual meeting of the Heart Rhythm Society, held from April 29 to May 1 in San Francisco.
Jeff Healey, M.D., from the Population Health Research Institute at McMaster University in Hamilton, Canada, and colleagues randomly assigned ICD-eligible patients (
The researchers found that major lead complications occurred in one patient (0.4 percent) with S-ICD versus 12 (4.8 percent) with TV-ICD (odds ratio, 0.08; 95 percent confidence interval, 0.00 to 0.55; P = 0.003). While not a significant difference, there was a trend toward more inappropriate shocks with S-ICD versus TV-ICD (6.4 versus 2.8 percent; odds ratio, 2.38; 95 percent confidence interval, 0.96 to 5.90) and failed appropriate clinical shocks (3.2 versus 2.0 percent). There was no significant difference seen in sudden death between the groups (0.8 and 1.2 percent, respectively).
“The S-ICD greatly reduces perioperative, lead-related complications without significantly compromising ICD performance,” Healey said in a statement. “The S-ICD is now an attractive alternative to the TV-ICD, particularly in patients at increased risk for lead-related complications.”
The study was funded by Boston Scientific.
Learn More